| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.24 | 0.0009 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |